Digestive Enzyme Wound Healing Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chronic wounds, such as skin ulcers, often fail to heal due to prolonged inflammation and are resistant to treatment with conventional antibiotics, leading to significant healthcare burdens and decreased quality of life.
Innovation Solution
A topical pharmaceutical composition containing digestive enzymes, such as porcine pancreatic enzymes, is used to stimulate wound healing by promoting epidermal cell growth, reducing scarring, and enhancing tissue integrity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional antibiotics are applied to clear bacterial infestation, then bacterial infestation is reduced, but wound healing is not promoted and tolerance or side effects occur
Solution Approach 1:
The patent applies proteases (digestive enzymes) to wounds, converting the harmful accumulation of necrotic tissue and fibrin into beneficial effects. These enzymes break down the harmful debris that perpetuates inflammation, thereby converting a harmful substance into a therapeutic mechanism that promotes wound healing and reduces inflammation simultaneously
Solution Approach 2:
The patent replaces the mechanical/chemical action of antibiotics with an enzymatic system. Instead of using antimicrobial agents to fight infection, the invention uses proteases to mechanically break down necrotic tissue and fibrin, creating a cleaner wound environment that naturally resists infection while promoting healing
2Object-affected harmful factors
If antibiotics are used to treat chronic wounds, then bacterial infestation is cleared, but the wounds remain resistant to treatment and side effects occur
Solution Approach 1:
The proteases convert the harmful necrotic tissue and fibrin accumulation into beneficial effects by breaking them down. This enzymatic degradation removes the barrier to healing and reduces inflammation, thereby converting what was previously harmful into a therapeutic mechanism that accelerates wound healing
Solution Approach 2:
The patent changes the therapeutic parameter from antimicrobial activity to enzymatic degradation activity. By using proteases with specific proteolytic activity rather than antibiotics, the treatment parameter shifts from fighting bacteria directly to removing the necrotic tissue that prevents healing, thereby improving the wound healing rate
3Object-affected harmful factors
If chemical drugs are applied to wounds, then bacterial infestation is controlled, but tolerance and side effects develop in users
Solution Approach 1:
The patent replaces chemical antibiotic action with enzymatic action. Proteases work through biochemical catalysis to break down proteins in necrotic tissue, rather than through the chemical mechanisms of antibiotics. This substitution eliminates the development of antibiotic resistance and reduces side effects while maintaining effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition accelerates wound healing, reduces scarring, and enhances epidermal restoration, demonstrating a significant improvement in wound closure and tissue integrity compared to placebo treatments.
Implementation Method 1
The enzyme compositions and methods disclosed herein relate to the use of digestive enzymes, such as pancreatic or other digestive-tract enzymes (e.g., porcine pancreatic enzymes) that break down components of food
Data Source
Figure 1A~1B
Figure 2A~2B
Figure 3A~3D
AI summary
Compositions and methods of using the compositions for wound healing are provided. The compositions include one or more digestive enzymes, for example, one or more protease, lipases, and amylases. The compositions can be formulated as topical pharmaceutical compositions and can be used for faster healing through stimulation of epidermal cells in the absence of scarring. The compositions may deposit a short term fibrosis and help prevent re-opening of wounds. The compositions may improve recruitment of white blood cells, thereby inducing or enhancing growth factor and immune system activation via an enzyme antibiotic effect. The compositions may enhance the epidermal integrity beyond that of the normal physiological restorative process. Application of the compositions may result in greater re-growth of hair on regions of wounds healed with enzyme and reduced alopecia. The compositions may be administered without causing allergic reactions and without causing biological damage or burns.